Bioject Medical Technologies In (BJCT) 0.0800 $BJCT
Global Needle-free Drug Delivery Technologies market 2015-2019: Key Vendors are 3M, Antares Pharma, Bioject Medical Technologies, Glide Pharmaceutical Technologies, PharmaJet and Zogenix
PR Newswire Europe - Wed Jan 28, 10:25AM CST
DUBLIN, Jan. 27, 2015 /PRNewswire/ --Research and Markets
ATRS: 2.14 (+0.06)
Global Needle-free Drug Delivery Technologies market 2015-2019 3M, Antares Pharma, Bioject Medical Technologies, Glide Pharmaceutical Technologies, PharmaJet & Zogenix Dominating
M2 - Thu Jan 15, 4:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/rt6m7j/global) has announced the addition of the "Global Needle-free Drug Delivery Technologies market 2015-2019" report to their offering. The Global Needle-free Drug Delivery Technologies market to grow at a CAGR of 13.5% over the period 2014-2019 This report covers the present scenario and the growth prospects of the Global Needle-free Drug Delivery Technologies market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various needle-free drug delivery systems with active mechanisms for skin permeation such as velocity, ultrasound, iontophoresis, thermo ablation, and electrophoresis. The introduction and enforcement of various laws mandating the use of safety needles/syringes and needle-free devices are one of the major trends in this market. With the introduction and enforcement of such laws, the Healthcare and Pharmaceuticals markets worldwide are now switching to the mandatory use of safety needles/syringes and needle-free devices to help protect those at risk of infection from NSIs and other unsafe injection practices. According to the report, increased safety and efficiency are the key factors responsible for the growth of the market. Needle-free drug delivery systems provide better acceptability, particularly in self-administration settings. Further, the report states that needle-free drug delivery systems are associated with increased technology because of which there is a decrease in the rate of adoption. These devices require training modules and instruction manuals for the users. This mode of drug delivery includes: - Jet Injectors - Transdermal Patches (Microneedles, Nanopatches) Key Vendors - 3M - Antares Pharma - Bioject Medical Technologies - Glide Pharmaceutical Technologies - PharmaJet - Zogenix For more information visit http://www.researchandmarkets.com/research/rt6m7j/global
ATRS: 2.14 (+0.06)
Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines
PRWeb - Fri Dec 19, 8:03AM CST
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that it has entered into an agreement with Immunomic Therapeutics, Inc. ("ITI"
for ITI to use the Bioject's Biojector(R)-2000 needle-free injection device with its LAMP™ vaccine platform.
Global Insulin Delivery Devices Market 2014-2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
M2 - Tue Jun 24, 3:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6qt2hc/insulin_delivery) has announced the addition of the "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" report to their offering. 'Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil. - Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. - Annualized market revenue data forecast to 2019 and company share data for 2012. - Qualitative analysis of key trends in the insulin delivery devices market. - Information on the competitive landscape and the leading technologies of key players: Novo Nordisk A/S, Medtronic, Inc., Sanofi, Eli Lilly and Company, Becton, Dickinson and Company, Animas Corporation, Insulet Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories. - Information on reimbursement trends and market access for key countries. Reasons to buy - Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market. - Design and enhance your product development, marketing, and sales strategies. - Exploit M&A opportunities by identifying the market players with the most innovative pipelines. - Develop market-entry and market-expansion strategies. - Identify the key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return. - Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape. - Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Diabetes - Disease Overview 4 Diabetes - Epidemiology 5 Global Insulin Delivery Devices Market: Device Overview 6 Global Insulin Delivery Devices Market: Market Characterization 7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 9 Global Insulin Delivery Devices Market: Reimbursement System 10 Global Insulin Delivery Devices Market: Competitive Landscape 11 Global Insulin Delivery Devices Market: Product Pipeline Analysis 12 Global Insulin Delivery Devices Market: Consolidation Landscape 13 Appendix Companies Mentioned - Abbott Laboratories - Animas - Antares Pharma - Asante Solutions - Becton, Dickinson and Company - Bioject Medical Technologies - Eli Lilly - F. Hoffmann-La Roche - Injex - Equidyne Systems - Insulet - Medtronic - Novo Nordisk (Subsidiary of Novo A/S) - Owen Mumford - Sanofi - Shanghai Fosun Pharmaceutical - Tandem Diabetes Care - Tonghua Dongbao Pharmaceutical - Ypsomed For more information visit http://www.researchandmarkets.com/research/6q...n_delivery
ABT: 48.84 (+0.13), PODD: 27.85 (+0.84), NVO: 56.92 (+0.17), MDT: 77.47 (+1.05), LLY: 72.94 (+0.04), ATRS: 2.14 (+0.06)
Global Needle-free Drug Delivery Technologies market 2015-2019: Key Vendors are 3M, Antares Pharma, Bioject Medical Technologies, Glide Pharmaceutical Technologies, PharmaJet and Zogenix
PR Newswire Europe - Wed Jan 28, 10:25AM CST
DUBLIN, Jan. 27, 2015 /PRNewswire/ --Research and Markets
ATRS: 2.14 (+0.06)
Global Needle-free Drug Delivery Technologies market 2015-2019 3M, Antares Pharma, Bioject Medical Technologies, Glide Pharmaceutical Technologies, PharmaJet & Zogenix Dominating
M2 - Thu Jan 15, 4:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/rt6m7j/global) has announced the addition of the "Global Needle-free Drug Delivery Technologies market 2015-2019" report to their offering. The Global Needle-free Drug Delivery Technologies market to grow at a CAGR of 13.5% over the period 2014-2019 This report covers the present scenario and the growth prospects of the Global Needle-free Drug Delivery Technologies market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various needle-free drug delivery systems with active mechanisms for skin permeation such as velocity, ultrasound, iontophoresis, thermo ablation, and electrophoresis. The introduction and enforcement of various laws mandating the use of safety needles/syringes and needle-free devices are one of the major trends in this market. With the introduction and enforcement of such laws, the Healthcare and Pharmaceuticals markets worldwide are now switching to the mandatory use of safety needles/syringes and needle-free devices to help protect those at risk of infection from NSIs and other unsafe injection practices. According to the report, increased safety and efficiency are the key factors responsible for the growth of the market. Needle-free drug delivery systems provide better acceptability, particularly in self-administration settings. Further, the report states that needle-free drug delivery systems are associated with increased technology because of which there is a decrease in the rate of adoption. These devices require training modules and instruction manuals for the users. This mode of drug delivery includes: - Jet Injectors - Transdermal Patches (Microneedles, Nanopatches) Key Vendors - 3M - Antares Pharma - Bioject Medical Technologies - Glide Pharmaceutical Technologies - PharmaJet - Zogenix For more information visit http://www.researchandmarkets.com/research/rt6m7j/global
ATRS: 2.14 (+0.06)
Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines
PRWeb - Fri Dec 19, 8:03AM CST
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that it has entered into an agreement with Immunomic Therapeutics, Inc. ("ITI"
for ITI to use the Bioject's Biojector(R)-2000 needle-free injection device with its LAMP™ vaccine platform. Global Insulin Delivery Devices Market 2014-2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
M2 - Tue Jun 24, 3:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6qt2hc/insulin_delivery) has announced the addition of the "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" report to their offering. 'Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil. - Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. - Annualized market revenue data forecast to 2019 and company share data for 2012. - Qualitative analysis of key trends in the insulin delivery devices market. - Information on the competitive landscape and the leading technologies of key players: Novo Nordisk A/S, Medtronic, Inc., Sanofi, Eli Lilly and Company, Becton, Dickinson and Company, Animas Corporation, Insulet Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories. - Information on reimbursement trends and market access for key countries. Reasons to buy - Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market. - Design and enhance your product development, marketing, and sales strategies. - Exploit M&A opportunities by identifying the market players with the most innovative pipelines. - Develop market-entry and market-expansion strategies. - Identify the key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return. - Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape. - Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Diabetes - Disease Overview 4 Diabetes - Epidemiology 5 Global Insulin Delivery Devices Market: Device Overview 6 Global Insulin Delivery Devices Market: Market Characterization 7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 9 Global Insulin Delivery Devices Market: Reimbursement System 10 Global Insulin Delivery Devices Market: Competitive Landscape 11 Global Insulin Delivery Devices Market: Product Pipeline Analysis 12 Global Insulin Delivery Devices Market: Consolidation Landscape 13 Appendix Companies Mentioned - Abbott Laboratories - Animas - Antares Pharma - Asante Solutions - Becton, Dickinson and Company - Bioject Medical Technologies - Eli Lilly - F. Hoffmann-La Roche - Injex - Equidyne Systems - Insulet - Medtronic - Novo Nordisk (Subsidiary of Novo A/S) - Owen Mumford - Sanofi - Shanghai Fosun Pharmaceutical - Tandem Diabetes Care - Tonghua Dongbao Pharmaceutical - Ypsomed For more information visit http://www.researchandmarkets.com/research/6q...n_delivery
ABT: 48.84 (+0.13), PODD: 27.85 (+0.84), NVO: 56.92 (+0.17), MDT: 77.47 (+1.05), LLY: 72.94 (+0.04), ATRS: 2.14 (+0.06)
